Public Release: 

Pre-existing inflammation may promote the spread of cancer

New research in the May 2015 issue of the Journal of Leukocyte Biology suggests that inflammation raises levels of chitinase-3-like-1, a known biomarker of cancer

Federation of American Societies for Experimental Biology

A new research report appearing in the May 2015 issue of the Journal of Leukocyte Biology suggests that allergic reactions--or at least the pre-existing inflammation from these reactions--may set the stage for cancer to spread from one area to another. Specifically, the report uses mice to show that inflammation raises the level of a known biomarker of cancer, called "chitinase-3-like-1" or "CHI3L1," in the inflamed tissue, which leads to increased metastasis and faster cancer growth in that tissue.

"The research we have done is striking in that we showed pre-existing inflammation may be one of the factors that accelerates metastasis to the inflamed site" said Vijaya L. Iragavarapu-Charyulu, Ph.D., the principle investigator of the study from the Charles E. Schmidt College of Medicine at Florida Atlantic University. "We hope that this study is a fundamental building block for future studies on how other inflammatory diseases may predispose patients for increased metastasis."

To make their discovery, Iragavarapu's group used two groups of mice, one of which was genetically modified so it could not produce the CHI3L1 glycoprotein. Then they induced the two groups of mice to become asthmatic, after which the mice were challenged with breast cancer cells. After four weeks researchers observed that there was less inflammation in the mice lacking CHI3L1 expression, and that the tumors in these mice did not grow as fast. These mice also had less metastasis to the lungs. This proved that CHI3L1was an important inflammatory protein that promoted tumor growth and metastasis.

"There is increasing evidence of a link between inflammation and cancer," said John Wherry, Ph.D., Deputy Editor of the Journal of Leukocyte Biology. "While normally inflammation helps us fight of infections, chronic inflammation has been linked to increased risk of tumor development. These new studies begin to shed light on an important way this link between inflammation and malignancy may work, providing a potential starting point for developing inflammation-based therapeutics to treat cancer."

###

The Journal of Leukocyte Biology publishes peer-reviewed manuscripts on original investigations focusing on the cellular and molecular biology of leukocytes and on the origins, the developmental biology, biochemistry and functions of granulocytes, lymphocytes, mononuclear phagocytes and other cells involved in host defense and inflammation. The Journal of Leukocyte Biology is published by the Society for Leukocyte Biology.

Details: Stephania Libreros, Ramon Garcia-Areas, Patricia Keating, Nathalia Gazaniga, Philip Robinson, Alison Humbles, and Vijaya L. Iragavarapu-Charyulu. Allergen induced pulmonary inflammation enhances mammary tumor growth and metastasis: Role of CHI3L1. J Leukoc Biol. doi:10.1189/jlb.3A0214-114RR

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.